BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5387389)

  • 1. [Effect of lidoflazine (1-(4,4-bis-(p. flurophenyl)-butyl)-4-(2,6-dimethylanilino-carbonyl)-methyl piperazine) on the ECG changes induced with pitressin in rats].
    Setti L; Razzaboni G
    Boll Soc Ital Biol Sper; 1969 Sep; 45(18):1192-3. PubMed ID: 5387389
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of lidoflazine on the exercise capacity of normal volunteers: double-blind cycloergometric evaluations.
    Jageneau A; Brugmans J
    Arzneimittelforschung; 1972 Feb; 22(2):457-9. PubMed ID: 4554634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrocardiographic studies on the drug Clinium].
    Széplaki S; Böszörményi E; Werkner J; Szmandra J
    Orv Hetil; 1974 Jan; 115(1):25-8. PubMed ID: 4809138
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamic study of a new cardiovascular drug: 4-(3',4',5'-trimethoxycinnamoyl)-1-(N-isopropylcarbamoylmethyl) piperazine maleate].
    Pourrias B; Bouvet P; Raynaud G
    Therapie; 1974; 29(2):233-50 passim. PubMed ID: 4849377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antagonistic action of reserpine and bretylium against electrocardiographic changes induced with pitressin in rats].
    Setti L; Razzaboni G; Vitolo A
    Boll Soc Ital Biol Sper; 1969 Apr; 45(7):414-6. PubMed ID: 5355877
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in ECG due to lidoflazine in subjects without coronary heart disease during rest and under cycloergometric conditions].
    Lehmann HU; Scholle J; Hochrein H
    Med Welt; 1974 Sep; 25(39):1556-63. PubMed ID: 4427554
    [No Abstract]   [Full Text] [Related]  

  • 8. Time course of effect of piperazine citrate on the electrocardiogram of the rat.
    Ghasi S; Onuaguluchi G
    Am J Ther; 2007; 14(6):524-32. PubMed ID: 18090878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chorionic gonadotropin and coronary circulation: inhibition of coronary spasm caused by pitressin].
    De Gregorio G; Buda A
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1718-21. PubMed ID: 5877914
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 11. Modulation of ventricular arrhythmias by catecholamines during evolving infarction in the isolated perfused rat heart.
    Clements-Jewery H; Curtis MJ
    Proc West Pharmacol Soc; 2001; 44():107-8. PubMed ID: 11793952
    [No Abstract]   [Full Text] [Related]  

  • 12. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique.
    Borgers M; Thoné F; van Nueten JM
    Acta Histochem Suppl; 1981; 24():327-32. PubMed ID: 6165047
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiac action of beta-blocking drugs. VI. dl-INPEA can be made capable of preventing the electrocardiographic effects of pitressin by use of aminophylline].
    Greggia A; Razzaboni G; Setti L
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1780-3. PubMed ID: 5733067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of adrenergic beta receptor blocking with propranolol on the electrocardiographic changes caused by pitressin].
    Romeo F; Squadrito G; Nicita-Mauro V
    Atti Soc Ital Cardiol; 1968; 2():77-81. PubMed ID: 5743877
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new vasodilator derivative of piperazine: 1-(3,4-dimethoxybenzyl)-piperazine. I. Chemical study. II. Pharmacological study].
    QUESNEL G; CHALAUST R; SCHMITT H; KRONEBERG G; SCHMITT H
    Arch Int Pharmacodyn Ther; 1960 Oct; 128():17-30. PubMed ID: 13738683
    [No Abstract]   [Full Text] [Related]  

  • 16. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of a (fluorophenyl) piperazine derivative (substance IIIv) on cardiovascular function].
    Mlynárová R; Tazká D; Racanská E; Kyselovic J; Svec P
    Ceska Slov Farm; 2000 Jul; 49(4):177-80. PubMed ID: 10953467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Piperazine-derivatives. II. Effect of piperazine-derivatives].
    Lányi K; Erdélyi I; Institoris E; Tardos L; Szabó Z
    Arzneimittelforschung; 1968 Nov; 18(11):1431-5. PubMed ID: 5755908
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of the coronary collateral circulation by lidoflazine (R 7904).
    Schaper WK; Xhonneux R; Jageneau AH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):1-8. PubMed ID: 4222721
    [No Abstract]   [Full Text] [Related]  

  • 20. The cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.
    Grover GJ; Sleph PG
    J Pharmacol Exp Ther; 1994 Jan; 268(1):90-6. PubMed ID: 8301599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.